宫颈癌

ɡōnɡ jǐnɡ ái
  • cervical carcinoma
宫颈癌宫颈癌
  1. CT模拟定位在宫颈癌术后辅助放射治疗中的必要性

    The importance of CT-simulation in postoperative radiotherapy of cervical carcinoma

  2. ⅠB2期宫颈癌不同治疗方法的疗效比较及其预后分析

    Analysis of the efficacy of different therapeutic methods and prognostic factors in stage ⅰ B_2 cervical carcinoma

  3. 宫颈癌的前兆是什么样的`

    Of palace neck cancer augural what kind of ' be ?

  4. MRI评估宫颈癌病变范围的临床分析

    Evaluation of magnetic resonance imaging in cervical carcinoma staging

  5. 宫颈癌组织中上皮钙黏蛋白mRNA的表达及血清可溶性钙黏蛋白测定的意义

    Expression of E-cadherin mRNA and concentration of serum soluble E-cadherin in cervix cancer

  6. 宫颈癌p53和增殖细胞核抗原的关系研究

    The Relation between p53 and Proliferation Cell Nuclear Antigen in Cervical Carcinoma

  7. MRI评价宫颈癌在放疗中形态和体积变化的临床意义

    MRI in the assessment of change in size and morphology of cervical cancer during radiation therapy

  8. 钴(~(60)Co)源外放疗加后装治疗宫颈癌疗效观察

    ~ ( 60 ) Co External Beam Radiotherapy and Intracavitary Afterloading Radiotherapy for Carcinoma of Uterine Cervix

  9. 结论宫颈癌组织的突变型P53蛋白的表达在动脉介入化疗前后有显著性差异,动脉介入化疗可能诱导宫颈癌组织中突变型P53蛋白的表达。

    Conclusion Intra-arterial infusion chemotherapy may induce the expression of mutant P53 protein .

  10. 宫颈癌组织中P53基因5~6外显子的检测及分析

    Detection and Analysis of P53 Gene 5 ~ 6 Exon in Cervical Carcinoma

  11. 宫颈癌组织中HPV和p53基因表达的检测

    Detection of HPV and p53 gene expressions in cervical cancer tissue

  12. 结果宫颈癌Ⅱb期术中放疗组与单纯放疗组5年生存率分别是95%和88%,两组比较,差异无显著性(P>005);

    Results The 5-year survival rate in the IORT group was 95 % , and that in the single radiotherapy group 88 % .

  13. [目的]探讨DNA拓扑异构酶Ⅰ抑制剂&拓扑替康在宫颈癌治疗中的抗癌活性。

    [ Purpose ] To investigate the anti-cancer activity of topoisomerase ⅰ inhibitor ( topotecan ) in the treatment for cervical cancer .

  14. 宫颈癌及癌旁组织中人乳头瘤病毒DNA检测

    Detection of human papilloma virus DNA in tissue of cervical carcinoma and tissue near to carcinoma by in situ polymerase chain reaction

  15. 改良的甲基化特异PCR法在人宫颈癌Hela细胞检测中的应用

    Detection of human cervical carcinoma Hela cell by methylation specific polymerase chain reaction

  16. 人宫颈癌bcl-2基因表达与预后的关系

    Relationship between the expression of bcl-2 gene in human cervical carcinoma and its prognosis

  17. P(21)~(ras)在人宫颈癌中的表达及其临床意义

    Clinical Significance on Expression of the ras Gene Product P_ ( 21 ) in Human Cervical Carcinoma Tissues

  18. 结果显示,宫颈癌组DNA指数平均值明显高于正常组,且与肿瘤细胞分化有关;

    The results showed that the DI in cervical cancer was higher than in normal group and was related with tumor cell differentiation .

  19. 高剂量率~(60)Co腔内后装治疗宫颈癌的参考体积和参考点剂量

    The Reference Dose and Volume of High Dose Rate ~ ( 60 ) Co Intracavitary Therapy of Uterine Cervical Cancer

  20. 抗凋亡基因survivin与宫颈癌

    An anti - apoptosis gene survivin and the cervical cancer

  21. 凋亡抑制基因Survivin与宫颈癌的发生

    Expression of Apoptotic Inhibiting Gene Survivin and Uterine Cervical Carcinogenesis

  22. 三氧化二砷诱导人宫颈癌细胞凋亡及bcl-2高表达对其影响

    Arsenic trioxide induced human cervical cancer cell apoptosis and effect of bcl 2 overexpression on it

  23. 宫颈癌前病变与女性HPV生殖道感染关系的探讨

    The Relationship Between HPV Infection in Female Reproductive Tract and the Cervical Precancerosis

  24. 目的探讨湖北土家族人群HLAA2超型各等位基因与宫颈癌的关联。

    Objective To explore the association between HLA-A2 supertype alleles and cervical carcinoma .

  25. TRAIL及其死亡受体在宫颈癌组织中的表达和临床意义

    Expressions of TRAIL and its death receptor in tissue of cervical carcinoma and its clinical significance

  26. 结论:(1)HPV感染是导致妇女宫颈癌及癌前病变好发、多发的主要病因。

    Conclusions ( 1 ) HPV is one of main factors for cervical neoplasia .

  27. 抑癌基因ING1、P21/WAF1、P53蛋白在宫颈癌中的表达

    Expression of suppressor gene P 33ING_1 , P21 / WAF_1 and P53 protein in cervical carcinoma

  28. 脂质体转染survivin反义寡核苷酸增加宫颈癌细胞对放、化疗敏感性的实验研究

    Survivin Antisense Oligonucleotide Transfection by Liposome Sensitizes Cervical Cancer Cells to Chemotherapy and Radiotherapy

  29. Rb可能主要通过功能性失活参与宫颈癌的发生。

    Rb may be functionally inactivated in cervical cancer .

  30. 宫颈癌HPV感染及其与hMLH1、PCNA表达状态的关系

    Human Papillomavirus Infection and Its Relationship between hMLH_1 、 PCNA Expression in Human Cervical Carcinoma